Company / R&D per Share
PLUS THERAPEUTICS, INC. R&D per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.79
FY2025
5-year range
$0.08 / $2.18
FY2021-FY2025
Trend
-17.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.08 in FY2017 to $2.18 in FY2024.
Based on SEC 10-K filings.
1.79 in FY2025 with a 10-year CAGR of +26.4%.
Declined from $2.02 to $1.79 over the past 7 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +26.4%
Key checks
Key Insights
- In FY2025, r&d per share decreased 17.7% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.79 | -17.7% |
| FY2024 | $2.18 | +8.0% |
| FY2018 | $2.02 | +2393.7% |
| FY2017 | $0.08 | -94.5% |
| FY2016 | $1.46 | +750.6% |
| FY2015 | $0.17 | -10.1% |
| FY2014 | $0.19 | +15.5% |
| FY2013 | $0.17 | -3.4% |
| FY2012 | $0.17 | -27.3% |
| FY2011 | $0.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026